Journal
JOURNAL OF NEUROCHEMISTRY
Volume 87, Issue 1, Pages 101-106Publisher
BLACKWELL PUBLISHING LTD
DOI: 10.1046/j.1471-4159.2003.01980.x
Keywords
BDNF; brain trauma; huntingtin; Huntington's disease; ischemia; spinal cord injury
Categories
Funding
- Telethon [GGP02215] Funding Source: Medline
Ask authors/readers for more resources
Huntington's disease (HD) is caused by a mutation in the gene encoding for huntingtin resulting in selective neuronal degeneration. Because HD is an autosomal dominant disorder, affected individuals have one copy of the mutant and one copy of the wild-type allele. Huntingtin has antiapoptotic properties and is critical for cell survival. However, the important role of wild-type huntingtin in both HD and other neurological diseases has not been fully recognized. We demonstrate disease-associated decreased levels of full-length huntingtin in brains of transgenic mouse models of HD, ischemia, trauma, and in spinal cord after injury. In addition, overexpression of wild-type huntingtin confers in vivo protection of neurodegeneration after ischemia. We propose that in HD, in addition to a toxic gain-of-function of mutant huntingtin, a parallel depletion of wild-type huntingtin results in a detrimental loss-of-function, playing an important role in disease progression.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available